215 related articles for article (PubMed ID: 26372519)
21. Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity.
Zepeda-Romero LC; Vazquez-Membrillo M; Adan-Castro E; Gomez-Aguayo F; Gutierrez-Padilla JA; Angulo-Castellanos E; Barrera de Leon JC; Gonzalez-Bernal C; Quezada-Chalita MA; Meza-Anguiano A; Diaz-Lezama N; Martinez de la Escalera G; Triebel J; Clapp C
Pediatr Res; 2017 Mar; 81(3):473-479. PubMed ID: 27842054
[TBL] [Abstract][Full Text] [Related]
22. Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants.
Vinekar A; Nair AP; Sinha S; Vaidya T; Chakrabarty K; Shetty R; Ghosh A; Sethu S
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):2. PubMed ID: 33646290
[TBL] [Abstract][Full Text] [Related]
23. The Alteration and Significance of Erythropoietin Serum Levels in Preterm Infants with Retinopathy of Prematurity.
Yang X; Ze B; Dai Y; Zhu L; Chen C
Am J Perinatol; 2017 Aug; 34(10):1020-1025. PubMed ID: 28395368
[No Abstract] [Full Text] [Related]
24. Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity.
Hellgren G; Löfqvist C; Hansen-Pupp I; Gram M; Smith LE; Ley D; Hellström A
Growth Horm IGF Res; 2018 Apr; 39():19-24. PubMed ID: 29274846
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Plasma Cytokine Profile Changes in Bevacizumab-Treated Retinopathy of Prematurity Infants.
Kong L; Demny AB; Sajjad A; Bhatt AR; Devaraj S
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1649-54. PubMed ID: 27054517
[TBL] [Abstract][Full Text] [Related]
26. The Serum Levels of Asymmetric Dimethylarginine, Vascular Endothelial Growth Factor, and Insulin-Like Growth Factor-1 in Preterms with Retinopathy of Prematurity.
Aydoğan S; Dilli D; Kabataş EU; Akduman H; Şah Ipek M; Oğuz B; Ataş N; Zenciroğlu A
Fetal Pediatr Pathol; 2022 Aug; 41(4):634-639. PubMed ID: 34289792
[No Abstract] [Full Text] [Related]
27. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity.
Sato T; Kusaka S; Shimojo H; Fujikado T
Ophthalmology; 2009 Sep; 116(9):1599-603. PubMed ID: 19371954
[TBL] [Abstract][Full Text] [Related]
28. Associations of VEGF/VEGF-receptor and HGF/c-Met promoter polymorphisms with progression/regression of retinopathy of prematurity.
Kaya M; Çokakli M; Berk AT; Yaman A; Yesilirmak D; Kumral A; Atabey N
Curr Eye Res; 2013 Jan; 38(1):137-42. PubMed ID: 23094709
[TBL] [Abstract][Full Text] [Related]
29. SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY.
Wu WC; Shih CP; Lien R; Wang NK; Chen YP; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC
Retina; 2017 Apr; 37(4):694-701. PubMed ID: 27467377
[TBL] [Abstract][Full Text] [Related]
30. The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study.
Woo SJ; Park KH; Lee SY; Ahn SJ; Ahn J; Park KH; Oh KJ; Ryu A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3434-9. PubMed ID: 23633656
[TBL] [Abstract][Full Text] [Related]
31. Immune and Inflammatory Proteins in Cord Blood as Predictive Biomarkers of Retinopathy of Prematurity in Preterm Infants.
Park YJ; Woo SJ; Kim YM; Hong S; Lee YE; Park KH
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3813-3820. PubMed ID: 31525777
[TBL] [Abstract][Full Text] [Related]
32. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I.
Löfqvist C; Hansen-Pupp I; Andersson E; Holm K; Smith LE; Ley D; Hellström A
Arch Ophthalmol; 2009 May; 127(5):622-7. PubMed ID: 19433710
[TBL] [Abstract][Full Text] [Related]
33. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity.
Sonmez K; Drenser KA; Capone A; Trese MT
Ophthalmology; 2008 Jun; 115(6):1065-1070.e1. PubMed ID: 18031819
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms of Vascular Endothelial Growth Factor and Retinopathy of Prematurity.
Ali AA; Hussien NF; Samy RM; Husseiny KA
J Pediatr Ophthalmol Strabismus; 2015; 52(4):245-53. PubMed ID: 25992764
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of IGF1 are a useful predictor of retinopathy of prematurity.
Pérez-Muñuzuri A; Fernández-Lorenzo JR; Couce-Pico ML; Blanco-Teijeiro MJ; Fraga-Bermúdez JM
Acta Paediatr; 2010 Apr; 99(4):519-25. PubMed ID: 20085549
[TBL] [Abstract][Full Text] [Related]
36. Plasma sE-selectin in premature infants: a possible surrogate marker of retinopathy of prematurity.
Pieh C; Krüger M; Lagrèze WA; Gimpel C; Buschbeck C; Zirrgiebel U; Agostini HT
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3709-13. PubMed ID: 20181841
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab.
Zhou Y; Jiang Y; Bai Y; Wen J; Chen L
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):31-6. PubMed ID: 25851862
[TBL] [Abstract][Full Text] [Related]
38. Retinopathy of Prematurity among Very-Low-Birth-Weight Infants in Korea: Incidence, Treatment, and Risk Factors.
Hwang JH; Lee EH; Kim EA
J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S88-94. PubMed ID: 26566363
[TBL] [Abstract][Full Text] [Related]
39. Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP.
Hellgren G; Lundgren P; Pivodic A; Löfqvist C; Nilsson AK; Ley D; Sävman K; Smith LE; Hellström A
Neonatology; 2021; 118(1):18-27. PubMed ID: 33611321
[TBL] [Abstract][Full Text] [Related]
40. Nucleated red blood cells in preterm infants with retinopathy of prematurity.
Lubetzky R; Stolovitch C; Dollberg S; Mimouni FB; Salomon M; Mandel D
Pediatrics; 2005 Nov; 116(5):e619-22. PubMed ID: 16199672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
